39065726|t|Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives.
39065726|a|The unintended modulation of nuclear receptor (NR) activity by drugs can lead to toxicities amongst the endocrine, gastrointestinal, hepatic cardiovascular, and central nervous systems. While secondary pharmacology screening assays include NRs, safety risks due to unintended interactions of small molecule drugs with NRs remain poorly understood. To identify potential nonclinical and clinical safety effects resulting from functional interactions with 44 of the 48 human-expressed NRs, we conducted a systematic narrative review of the scientific literature, tissue expression data, and used curated databases (OFF-X ) (Off-X, Clarivate) to organize reported toxicities linked to the functional modulation of NRs in a tabular and machine-readable format. The top five NRs associated with the highest number of safety alerts from peer-reviewed journals, regulatory agency communications, congresses/conferences, clinical trial registries, and company communications were the Glucocorticoid Receptor (GR, 18,328), Androgen Receptor (AR, 18,219), Estrogen Receptor (ER, 12,028), Retinoic acid receptors (RAR, 10,450), and Pregnane X receptor (PXR, 8044). Toxicities associated with NR modulation include hepatotoxicity, cardiotoxicity, endocrine disruption, carcinogenicity, metabolic disorders, and neurotoxicity. These toxicities often arise from the dysregulation of receptors like Peroxisome proliferator-activated receptors (PPARalpha, PPARgamma), the ER, PXR, AR, and GR. This dysregulation leads to various health issues, including liver enlargement, hepatocellular carcinoma, heart-related problems, hormonal imbalances, tumor growth, metabolic syndromes, and brain function impairment. Gene expression analysis using heatmaps for human and rat tissues complemented the functional modulation of NRs associated with the reported toxicities. Interestingly, certain NRs showed ubiquitous expression in tissues not previously linked to toxicities, suggesting the potential utilization of organ-specific NR interactions for therapeutic purposes.
39065726	204	214	toxicities	Disease	MESH:D064420
39065726	238	254	gastrointestinal	Disease	MESH:D005767
39065726	363	366	NRs	Gene	83985
39065726	441	444	NRs	Gene	83985
39065726	590	595	human	Species	9606
39065726	606	609	NRs	Gene	83985
39065726	784	794	toxicities	Disease	MESH:D064420
39065726	834	837	NRs	Gene	83985
39065726	893	896	NRs	Gene	83985
39065726	1099	1122	Glucocorticoid Receptor	Gene	2908
39065726	1137	1154	Androgen Receptor	Gene	367
39065726	1169	1186	Estrogen Receptor	Gene	2099
39065726	1188	1190	ER	Gene	2069
39065726	1226	1229	RAR	Gene	5914
39065726	1244	1263	Pregnane X receptor	Gene	8856
39065726	1265	1268	PXR	Gene	8856
39065726	1277	1287	Toxicities	Disease	MESH:D064420
39065726	1326	1340	hepatotoxicity	Disease	
39065726	1342	1356	cardiotoxicity	Disease	MESH:D066126
39065726	1358	1378	endocrine disruption	Disease	MESH:D004700
39065726	1380	1395	carcinogenicity	Disease	MESH:D011230
39065726	1397	1416	metabolic disorders	Disease	MESH:D008659
39065726	1422	1435	neurotoxicity	Disease	MESH:D020258
39065726	1443	1453	toxicities	Disease	MESH:D064420
39065726	1552	1561	PPARalpha	Gene	5465
39065726	1563	1572	PPARgamma	Gene	5468
39065726	1579	1581	ER	Gene	2069
39065726	1583	1586	PXR	Gene	8856
39065726	1661	1678	liver enlargement	Disease	MESH:D006529
39065726	1680	1704	hepatocellular carcinoma	Disease	MESH:D006528
39065726	1751	1756	tumor	Disease	MESH:D009369
39065726	1765	1784	metabolic syndromes	Disease	MESH:D024821
39065726	1790	1815	brain function impairment	Disease	MESH:D001927
39065726	1861	1866	human	Species	9606
39065726	1871	1874	rat	Species	10116
39065726	1925	1928	NRs	Gene	83985
39065726	1958	1968	toxicities	Disease	MESH:D064420
39065726	1993	1996	NRs	Gene	83985
39065726	2062	2072	toxicities	Disease	MESH:D064420
39065726	Association	MESH:D064420	5465
39065726	Association	MESH:D020258	83985
39065726	Association	MESH:D008659	2069
39065726	Association	MESH:D064420	83985
39065726	Association	MESH:D001927	8856
39065726	Association	MESH:D020258	5465
39065726	Association	MESH:D006529	2069
39065726	Association	MESH:D009369	8856
39065726	Association	MESH:D064420	5468
39065726	Association	MESH:D001927	2069
39065726	Association	MESH:D001927	5465
39065726	Association	MESH:D006528	5465
39065726	Association	MESH:D024821	8856
39065726	Association	MESH:D020258	8856
39065726	Association	MESH:D006529	5465
39065726	Association	MESH:D006528	8856
39065726	Association	MESH:D001927	5468
39065726	Association	MESH:D008659	8856
39065726	Association	MESH:D020258	5468
39065726	Association	MESH:D006529	8856
39065726	Association	MESH:D006528	2069
39065726	Association	MESH:D064420	2069
39065726	Association	MESH:D066126	5465
39065726	Association	MESH:D064420	8856
39065726	Association	MESH:D066126	8856
39065726	Association	MESH:D004700	8856
39065726	Association	MESH:D024821	2069
39065726	Association	MESH:D020258	2069
39065726	Association	MESH:D024821	5465

